Severe QT Prolongation Common in Users of Antipsychotic Medications

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 23, 2024.

By Lori Solomon HealthDay Reporter

TUESDAY, Jan. 23, 2024 -- More than one in eight patients receiving quetiapine or haloperidol therapy appear to develop severe QT prolongation (SQTP), according to a study published online Jan. 14 in Heart Rhythm.

Chun-Li Wang, M.D., from the Linkou Medical Center in Taoyuan, Taiwan, and colleagues examined the incidences, risk factors, and outcomes of SQTP in quetiapine and haloperidol users. The analysis included electronic health records from adult patients who ever used quetiapine (8,832 individuals) or haloperidol (2,341 individuals) with baseline and follow-up electrocardiograms.

The researchers found that mean increases in the posttreatment-corrected QT (QTc) interval were +8.3 and +8.9 ms after the administration of quetiapine and haloperidol, respectively. SQTP occurred in 13.0 percent of quetiapine and 14.2 percent of haloperidol users. For SQTP, common risk factors included old age, heart failure, hypokalemia, amiodarone use, and baseline QTc interval. There were significant associations for SQTP in quetiapine users and ventricular arrhythmias (odds ratio, 2.84) and sudden cardiac death (odds ratio, 2.29).

"Of the 41 drugs on the market in the United States that are listed as having a known risk of torsades de pointes, five are antipsychotic drugs, the mainstay of treatment of schizophrenia and psychosis," write the authors of an accompanying editorial. "The use of antipsychotic drugs is associated with an approximately twofold increased risk of sudden cardiac death. If we cannot eliminate this risk, then at the least we need to minimize the risk by identifying those patients who are at highest risk and managing them more closely."

Abstract/Full Text

Editorial

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-01-24 02:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords